{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:24:33Z","timestamp":1790727873543,"version":"4.1.0"},"reference-count":21,"publisher":"Portland Press Ltd.","issue":"3","license":[{"start":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T00:00:00Z","timestamp":1646265600000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The latest evidence suggests that type 2 endometrial cancer may not be completely oestrogen-independent, indicating that the status of hormonal change may not be associated with the traditional classification of endometrial cancer, including the histological subtypes. However, this has not been investigated. Menopause is commonly considered a state of hormonal change in women. In the present study, we investigated the association of menopause with the histological types of endometrial cancer. Data on the histological type, menopause status at diagnosis, age at diagnosis, parity, body mass index (BMI), and overall survival rate from 2122 cases were collected. The difference in risk in developing type 1 or type 2 endometrial cancer between premenopausal and postmenopausal patients was 5.457%. A statistical difference in the association of menopause with the histological types between the two groups was seen in endometrioid and serous carcinoma, with a risk difference of 5.6 or 3.8%. A statistical difference in the association of menopause with parity between the groups was only seen in endometrioid and adenosquamous carcinoma, with a risk difference of 7.1 or 3.7%. However, BMI was not associated with histological type and the overall survival rate was not associated with menopause (P=0.764). We reported a relatively small difference in the association of menopause with type 1 or type 2, or the histological types of endometrial cancer. The survival rate was not associated with menopause. Our study suggests that menopause status at diagnosis was not strongly associated with the histological subtypes of endometrial cancer.<\/jats:p>","DOI":"10.1042\/bsr20212192","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T09:24:38Z","timestamp":1646299478000},"update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The histological type of endometrial cancer is not associated with menopause status at diagnosis"],"prefix":"10.1042","volume":"42","author":[{"given":"Xinyi","family":"Sun","sequence":"first","affiliation":[{"name":"The Department of Obstetrics and Gynaecology, The University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Department of Obstetrics and Gynaecology, The University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Gynaecology, The Hospital of Obstetrics and Gynaecology, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[{"name":"The Department of Obstetrics and Gynaecology, The University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George\u00a0Qiaoqi","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Medicine, The University of Manchester, Manchester, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Gynaecology, The Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University, Wuxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5894-6331","authenticated-orcid":false,"given":"Qi","family":"Chen","sequence":"additional","affiliation":[{"name":"The Department of Obstetrics and Gynaecology, The University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"key":"2022031611572858700_B1","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/jnci\/djx214","article-title":"International Patterns and Trends in Endometrial Cancer Incidence, 1978-2013","volume":"110","author":"Lortet-Tieulent","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"2022031611572858700_B2","doi-asserted-by":"publisher","first-page":"e268","DOI":"10.1016\/S1470-2045(13)70591-6","article-title":"Classification of endometrial carcinoma: more than two types","volume":"15","author":"Murali","year":"2014","journal-title":"Lancet Oncol."},{"key":"2022031611572858700_B3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol. Oncol."},{"key":"2022031611572858700_B4","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","article-title":"Type I and II endometrial cancers: have they different risk factors?","volume":"31","author":"Setiawan","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"2022031611572858700_B5","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/ijc.22260","article-title":"Body size in relation to cancer of the uterine corpus in 1 million Norwegian women","volume":"120","author":"Bj\u00f8rge","year":"2007","journal-title":"Int. J. Cancer"},{"key":"2022031611572858700_B6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1158\/1055-9965.EPI-07-2567","article-title":"Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype","volume":"17","author":"McCullough","year":"2008","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"2022031611572858700_B7","doi-asserted-by":"publisher","first-page":"39744","DOI":"10.1038\/srep39744","article-title":"The levels of the sex hormones are not different between type 1 and type 2 endometrial cancer","volume":"6","author":"Wan","year":"2016","journal-title":"Sci. Rep."},{"key":"2022031611572858700_B8","doi-asserted-by":"publisher","first-page":"506","DOI":"10.18632\/oncotarget.13471","article-title":"Is the positivity of estrogen receptor or progesterone receptor different between type 1 and type 2 endometrial cancer?","volume":"8","author":"Shen","year":"2017","journal-title":"Oncotarget"},{"key":"2022031611572858700_B9","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1002\/ijc.33360","article-title":"Pregnancy outcomes and risk of endometrial cancer: a pooled analysis of individual participant data in the Epidemiology of Endometrial Cancer Consortium","volume":"148","author":"Jordan","year":"2021","journal-title":"Int. J. Cancer"},{"key":"2022031611572858700_B10","doi-asserted-by":"publisher","first-page":"CD003916","DOI":"10.1002\/14651858.CD003916.pub3","article-title":"Adjuvant radiotherapy for stage I endometrial cancer","volume":"2012","author":"Kong","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"2022031611572858700_B11","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1007\/s10552-010-9612-8","article-title":"Factors associated with Type I and Type II endometrial cancer","volume":"21","author":"Felix","year":"2010","journal-title":"Cancer Causes Control"},{"key":"2022031611572858700_B12","doi-asserted-by":"publisher","first-page":"vi33","DOI":"10.1093\/annonc\/mdt353","article-title":"Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Colombo","year":"2013","journal-title":"Ann. Oncol."},{"key":"2022031611572858700_B13","doi-asserted-by":"publisher","first-page":"8584130","DOI":"10.1155\/2019\/8584130","article-title":"Age at menopause and risk of developing endometrial cancer: a meta-analysis","volume":"2019","author":"Wu","year":"2019","journal-title":"Biomed Res. Int."},{"key":"2022031611572858700_B14","volume-title":"Tumours of the Uterine Corpus: Epithelial Tumours and Precursors","author":"Carinelli","year":"2014"},{"key":"2022031611572858700_B15","first-page":"107","article-title":"Obesity and Endometrial Cancer, Recent results in cancer research. Fortschritte der Krebsforschung","volume":"208","author":"Shaw","year":"2016","journal-title":"Progres Dans Les Recherches Sur Le Cancer"},{"key":"2022031611572858700_B16","first-page":"429","article-title":"Past, present, and future of hormonal therapy in recurrent endometrial cancer","volume":"6","author":"Carlson","year":"2014","journal-title":"Int. J. Womens Health"},{"key":"2022031611572858700_B17","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ygyno.2008.10.032","article-title":"Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer","volume":"112","author":"Jongen","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"2022031611572858700_B18","first-page":"963","article-title":"Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas","volume":"10","author":"Sherman","year":"1997","journal-title":"Mod. Pathol."},{"key":"2022031611572858700_B19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/modpathol.3880051","article-title":"Theories of endometrial carcinogenesis: a multidisciplinary approach","volume":"13","author":"Sherman","year":"2000","journal-title":"Mod. Pathol."},{"key":"2022031611572858700_B20","doi-asserted-by":"publisher","first-page":"S116","DOI":"10.1067\/mjd.2001.117432","article-title":"Estrogen production and action","volume":"45","author":"Nelson","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"key":"2022031611572858700_B21","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0140-6736(05)67063-8","article-title":"Endometrial cancer","volume":"366","author":"Amant","year":"2005","journal-title":"Lancet"}],"container-title":["Bioscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20212192\/931046\/bsr-2021-2192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20212192\/931046\/bsr-2021-2192.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T11:58:00Z","timestamp":1647431880000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/bioscirep\/article\/42\/3\/BSR20212192\/230977\/The-histological-type-of-endometrial-cancer-is-not"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3,31]]}},"URL":"https:\/\/doi.org\/10.1042\/bsr20212192","relation":{},"ISSN":["0144-8463","1573-4935"],"issn-type":[{"value":"0144-8463","type":"print"},{"value":"1573-4935","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,3]]},"published":{"date-parts":[[2022,3]]},"article-number":"BSR20212192"}}